StonvexLoading…
StonvexStonvexStonvexCore line items from RDNW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.08B | $1.21B | $1.37B | $1.46B |
Operating Income | $-200.00K | $-15.20M | $-69.50M | $-260.10M |
Net Income | $-52.40M | $-78.60M | $-215.50M | $-261.50M |
EPS (Diluted) | $-1.38 | $-2.22 | $-12.15 | $-16.48 |
Total Assets | $673.60M | $755.20M | $926.30M | $1.03B |
Total Liabilities | $686.10M | $718.50M | $820.70M | $821.20M |
Cash & Equivalents | $29.50M | $85.30M | $58.90M | $46.80M |
Free Cash Flow OCF − CapEx | $10.30M | $97.40M | $-52.60M | $-24.49M |
Shares Outstanding | 37.96M | 35.38M | 17.74M | 15.87M |